This is the first translational bioinformatics analysis in the coding region of ATL1 gene which aims to categorize nsSNPs that could be used as genomic biomarkers specifically before 4 years of age; also, it may play a key role in pharmacogenomics by evaluating drug response for this disabling disease [24–29]. Here, ATL1 is linked to glycogen storage disease VI.